Los especialistas piden un cribado de enfermedad hepática en consumidores habituales de alcohol, independientemente de su ...
Las inyecciones 'milagro' contra la obesidad sólo sirven si desarrollamos hábitos de vida saludable mientras las estamos ...
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to ...
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
Drugs like Ozempic have a positive impact on weight loss, though only for a short period, with long-term health implications ...
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
The risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is and with GLP-1 RAs versus DPP-4is.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback